5.Diagnosis and differentiation diagnosis of primary temporomandibular joint cartilage and giant cell related tumor lesions.
Shi Lei NI ; Zhi Min LI ; Hong Chen SUN
Chinese Journal of Stomatology 2022;57(11):1097-1101
Cartilage and giant cell-related neoplastic lesions originating in the temporomandibular joint region have similar clinical, imaging and pathological manifestations, making the diagnosis of these disorders challenging to varying degrees. Diagnostic findings can influence treatment procedures and a definitive pathological diagnosis is important for the prognosis of these conditions. In this article, we discuss the pathological diagnosis and differentiation of four benign cartilage and giant cell related tumors and tumor-like lesions that occur in the temporomandibular joint, namely synovial chondromatosis, tumoral calcium pyrophosphate deposition disease, pigmented villonodular synovitis and chondroblastoma, taking into account their clinical features and histological manifestations, with a view to providing a basis for clinical management.
Humans
;
Temporomandibular Joint/pathology*
;
Chondromatosis, Synovial/pathology*
;
Synovitis, Pigmented Villonodular/pathology*
;
Giant Cells/pathology*
;
Cartilage
7.Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab
Young Ho KIM ; Ju Whi KIM ; Eun Joo LEE ; Gyeong Hoon KANG ; Hyoung Jin KANG ; Jin Soo MOON ; Jae Sung KO
Pediatric Gastroenterology, Hepatology & Nutrition 2020;23(2):180-187
Giant cell hepatitis with autoimmune hemolytic anemia (AHA) is a rare disease of infancy characterized by the presence of both Coombs-positive hemolytic anemia and progressive liver disease with giant cell transformation of hepatocytes. Here, we report a case involving a seven-month-old male infant who presented with AHA followed by cholestatic hepatitis. The clinical features included jaundice, pallor, and red urine. Physical examination showed generalized icterus and splenomegaly. The laboratory findings suggested warm-type AHA with cholestatic hepatitis. Liver biopsy revealed giant cell transformation of hepatocytes and moderate lobular inflammation. The patient was successfully treated with four doses of rituximab. Early relapse of hemolytic anemia and hepatitis was observed, which prompted the use of an additional salvage dose of rituximab. He is currently in clinical remission.
Anemia, Hemolytic
;
Anemia, Hemolytic, Autoimmune
;
Biopsy
;
Giant Cells
;
Hepatitis
;
Hepatocytes
;
Humans
;
Infant
;
Inflammation
;
Jaundice
;
Liver
;
Liver Diseases
;
Male
;
Pallor
;
Physical Examination
;
Rare Diseases
;
Recurrence
;
Rituximab
;
Splenomegaly
8.Application of low-crystalline carbonate apatite granules in 2-stage sinus floor augmentation: a prospective clinical trial and histomorphometric evaluation
Takayuki NAKAGAWA ; Keiko KUDOH ; Naoyuki FUKUDA ; Shohei KASUGAI ; Noriko TACHIKAWA ; Kiyoshi KOYANO ; Yasuyuki MATSUSHITA ; Masanori SASAKI ; Kunio ISHIKAWA ; Youji MIYAMOTO
Journal of Periodontal & Implant Science 2019;49(6):382-396
PURPOSE: The purpose of this study was to elucidate the efficacy and safety of carbonate apatite (CO₃Ap) granules in 2-stage sinus floor augmentation through the radiographic and histomorphometric assessment of bone biopsy specimens.METHODS: Two-stage sinus floor augmentation was performed on 13 patients with a total of 17 implants. Radiographic assessment using panoramic radiographs was performed immediately after augmentation and was also performed 2 additional times, at 7±2 months and 18±2 months post-augmentation, respectively. Bone biopsy specimens taken from planned implant placement sites underwent micro-computed tomography, after which histological sections were prepared.RESULTS: Postoperative healing of the sinus floor augmentation was uneventful in all cases. The mean preoperative residual bone height was 3.5±1.3 mm, and this was increased to 13.3±1.7 mm by augmentation with the CO₃Ap granules. The mean height of the augmented site had decreased to 10.7±1.9 mm by 7±2 months after augmentation; however, implants with lengths in the range of 6.5 to 11.5 mm could still be placed. The mean height of the augmented site had decreased to 9.6±1.4 mm by 18±2 months post-augmentation. No implant failure or complications were observed. Few inflammatory cells or foreign body giant cells were observed in the bone biopsy specimens. Although there were individual differences in the amount of new bone detected, new bone was observed to be in direct contact with the CO₃Ap granules in all cases, without an intermediate layer of fibrous tissue. The amounts of bone and residual CO₃Ap were 33.8%±15.1% and 15.3%±11.9%, respectively.CONCLUSIONS: In this first demonstration, low-crystalline CO₃Ap granules showed excellent biocompatibility, and bone biopsy showed them to be replaced with bone in humans. CO₃Ap granules are a useful and safe bone substitute for two-stage sinus floor augmentation.
Apatites
;
Biopsy
;
Bone Substitutes
;
Carbon
;
Dental Implants
;
Giant Cells, Foreign-Body
;
Humans
;
Individuality
;
Prospective Studies
;
Sinus Floor Augmentation
9.A Case of an Isolated Peripheral Giant Cell Granuloma in the Parotid Gland
Soo Jin KIM ; Ju Hyun YUN ; Sohl PARK ; Han Su KIM
Korean Journal of Head and Neck Oncology 2019;35(2):39-43
Peripheral giant cell granuloma (PGCG) is an benign non-neoplastic lesion most commonly occurring in oral cavity but extraoral PGCG is extremely rare. Recently, we experienced a case of an isolated PGCG in the parotid gland in 59-year-old man. FNAB findings and radiologic findings including CT and US were suggestive of Warthin's tumor. Partial parotidectomy was performed. Pathologic findings showed fibrillar connective tissue stroma with spindled, ovoid, and round histiocytes-like cells mixed with uneven multinuclear giant cells, small capillaries, hemorrhage, hemosiderin-laden macrophages, and necrosis which were consistent with giant cell granuloma. We report a case of an PGCG in parotid with a review of literature.
Capillaries
;
Connective Tissue
;
Giant Cells
;
Granuloma, Giant Cell
;
Hemorrhage
;
Humans
;
Macrophages
;
Middle Aged
;
Mouth
;
Necrosis
;
Parotid Gland
10.Three Cases of Recurrent Cheilitis Granulomatosa Treated with Variable Combination Therapy
Seung Pil HAM ; Hee Jae PARK ; Cheong Ha WOO ; Mira CHOI ; Hai Jin PARK
Korean Journal of Dermatology 2019;57(4):209-212
Cheilitis granulomatosa (CG) is a subset of orofacial granulomatosis (OFG) and considered to be a monosymptomatic form of Melkersson-Rosenthal syndrome (MRS), which is characterized by the triad of chronic lip swelling, facial paralysis, and fissured tongue. The labial swelling is thought to be associated with an orofacial swelling, which affects the chin, cheeks, and oral mucosa. Histologically, it is distinguished by noncaseating granulomas consisting of lymphohistiocytes and giant cells. Although systemic steroids with or without intralesional triamcinolone injections are the mainstay of treatment, and various agents have been proposed for this rare disease, no successful treatment modality has been reported in the literature yet. Herein, we present our experience with three different CG cases, which showed a varied level of positive response to the combination therapy.
Cheek
;
Cheilitis
;
Chin
;
Facial Paralysis
;
Giant Cells
;
Granuloma
;
Granulomatosis, Orofacial
;
Lip
;
Melkersson-Rosenthal Syndrome
;
Mouth Mucosa
;
Rare Diseases
;
Steroids
;
Tongue, Fissured
;
Triamcinolone

Result Analysis
Print
Save
E-mail